Shagun Singh
Stock Analyst at RBC Capital
(2.52)
# 2,306
Out of 4,944 analysts
222
Total ratings
49.21%
Success rate
-1.29%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $112 → $115 | $101.82 | +12.94% | 16 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Outperform | $330 → $350 | $309.63 | +13.04% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $45 → $25 | $11.11 | +125.12% | 3 | Aug 7, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $21 → $22 | $12.67 | +73.64% | 12 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $215 → $180 | $83.93 | +114.46% | 6 | Aug 5, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $130 → $135 | $119.64 | +12.84% | 22 | Aug 1, 2025 | |
| PEN Penumbra | Maintains: Outperform | $330 → $325 | $248.55 | +30.76% | 15 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $85 → $89 | $76.93 | +15.69% | 22 | Jul 25, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $605 → $615 | $478.19 | +28.61% | 15 | Jul 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $181 → $185 | $172.78 | +7.07% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.58 | +89.87% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $147 | $131.02 | +12.20% | 14 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $92.08 | +9.69% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $120 | $102.64 | +16.91% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $376.61 | +15.50% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $61.87 | +48.70% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $80.17 | +43.45% | 4 | Oct 25, 2024 |
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112 → $115
Current: $101.82
Upside: +12.94%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330 → $350
Current: $309.63
Upside: +13.04%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $11.11
Upside: +125.12%
Outset Medical
Aug 7, 2025
Maintains: Sector Perform
Price Target: $21 → $22
Current: $12.67
Upside: +73.64%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215 → $180
Current: $83.93
Upside: +114.46%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $119.64
Upside: +12.84%
Penumbra
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $248.55
Upside: +30.76%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $85 → $89
Current: $76.93
Upside: +15.69%
Intuitive Surgical
Jul 23, 2025
Maintains: Outperform
Price Target: $605 → $615
Current: $478.19
Upside: +28.61%
Johnson & Johnson
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $172.78
Upside: +7.07%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.58
Upside: +89.87%
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $131.02
Upside: +12.20%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $92.08
Upside: +9.69%
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $102.64
Upside: +16.91%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $376.61
Upside: +15.50%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $61.87
Upside: +48.70%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $80.17
Upside: +43.45%